Kabi Is Ready To Get More Aggressive On US Market Share

 
• By Aidan Fry
  
Chocolate_Cake
Fresenius Kabi is ready to act aggressively to defend its share of the US intravenous generics market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Policy & Regulation